US2006263353A1PendingUtilityA1
Methods for obtaining antibodies
Est. expiryAug 20, 2023(expired)· nominal 20-yr term from priority
G01N 33/582G01N 33/56972
47
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The invention is directed towards a method of enriching a population of cells in those cells that produce an antibody which recognises an antigen of interest. In particular, an untagged antigen is used in conjunction with a polyclonal antibody to isolate cells recognizing said antigen.
Claims
exact text as granted — not AI-modified1 . A method of enriching a population of cells in those cells which produce an antibody that recognises an antigen of interest, comprising:
a) bringing said population into contact with an antibody that recognises a marker which is essentially unique to those cells present in the population which are capable of producing an antibody, said antibody being attached to a first fluorescent label; b) bringing said population into contact with the antigen of interest; c) bringing said population into contact with a sample comprising an antibody that recognises said antigen, said antibody being attached to a second fluorescent label; and d) separating from the population those cells which are detectable by virtue of being associated with the first and second fluorescent labels.
2 . The method of claim 1 , wherein parts a), b), and c) are performed simultaneously and the performance optionally comprises at least one wash step.
3 . The method of claim 1 , wherein parts a) and b), or a) and c), or b) and c), are performed simultaneously and optionally comprise at least one wash step.
4 . The method of claim 1 , wherein parts a), b) and c) are performed consecutively in any order, and wherein each performance optionally comprises at least one wash step.
5 . The method of claim 1 , wherein part a) additionally comprises bringing said population into contact with an antibody that recognises a second marker essentially unique to those cells present in the population which are capable of producing an antibody, said antibody being labelled with a third label.
6 . The method of claim 1 , wherein the separation of the cells producing an antibody that recognises the antigen of interest is performed using fluorescence activated cell sorting.
7 . A method according to claim 1 additionally comprising:
a) culturing a plurality of those cells associated with the antigen-antibody-particle complex; b) screening the cultured cells to identify those cells capable of producing an antibody which recognises an antigen of interest; and c) isolating said antibody directly or indirectly from the cells.
8 . An antibody prepared directly or indirectly according to the method of claim 1 .
9 . A pharmaceutical composition comprising an antibody according to claim 8 and a pharmaceutically acceptable carrier.
10 . (canceled)
11 . (canceled)
12 . The method of claim 2 , wherein the separation of the cells producing an antibody that recognises the antigen of interest is performed using fluorescence activated cell sorting.
13 . The method of claim 4 , wherein the separation of the cells producing an antibody that recognises the antigen of interest is performed using fluorescence activated cell sorting.
14 . The method of claim 5 , wherein the separation of the cells producing an antibody that recognises the antigen of interest is performed using fluorescence activated cell sorting.
15 . A method according to claim 2 additionally comprising:
a) culturing a plurality of those cells associated with the antigen-antibody-particle complex; b) screening the cultured cells to identify those cells capable of producing an antibody which recognises an antigen of interest; and c) isolating said antibody directly or indirectly from the cells.
16 . A method according to claim 4 additionally comprising:
a) culturing a plurality of those cells associated with the antigen-antibody-particle complex; b) screening the cultured cells to identify those cells capable of producing an antibody which recognises an antigen of interest; and c) isolating said antibody directly or indirectly from the cells.
17 . A method according to claim 5 additionally comprising:
a) culturing a plurality of those cells associated with the antigen-antibody-particle complex; b) screening the cultured cells to identify those cells capable of producing an antibody which recognises an antigen of interest; and c) isolating said antibody directly or indirectly from the cells.
18 . A method according to claim 6 additionally comprising:
a) culturing a plurality of those cells associated with the antigen-antibody-particle complex; b) screening the cultured cells to identify those cells capable of producing an antibody which recognises an antigen of interest; and c) isolating said antibody directly or indirectly from the cells.
19 . An antibody prepared directly or indirectly according to the method of claim 5 .
20 . An antibody prepared directly or indirectly according to the method of claim 7.Join the waitlist — get patent alerts
Track US2006263353A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.